Cited by

• Pharmacokinetics and pharmacodynamics of alprenolol in the treatment of hypertension. II. Relationship to its effect on blood pressure and plasma renin activity.

  Collste P, Haglund K, Frisk-Holmberg M, Orme ML, Rawlins MD, Ostman J. Collste P, et al. Eur J Clin Pharmacol. 1976 Jun 15;10(2):89-95. doi: 10.1007/BF00609465. Eur J Clin Pharmacol. 1976. PMID: 964292
• Reversal of ethanol intoxications in humans: an assessment of the efficacy of propranolol.

  Alkana RL, Parker ES, Cohen HB, Birch H, Noble EP. Alkana RL, et al. Psychopharmacology (Berl). 1976 Dec 21;51(1):29-37. doi: 10.1007/BF00426317. Psychopharmacology (Berl). 1976. PMID: 827773 Clinical Trial.
• Proceedings: Comparison of some haemodynamic changes between central and intravenous administration of (plus or minus)-propranolol in anaesthetized dogs.

  Carter JK, Mitchell HW, Poyser RH. Carter JK, et al. Br J Pharmacol. 1974 May;51(1):146P-147P. Br J Pharmacol. 1974. PMID: 4441787 Free PMC article. No abstract available.
• Long term treatment of moderate hypertension with penbutolol (Hoe 893d). II. Effect on the response of plasma catecholamines and plasma renin activity to insulin-induced hypoglycemia.

  Hansson BG, Hökfelt. Hansson BG, et al. Eur J Clin Pharmacol. 1976 Feb 6;9(4):245-51. doi: 10.1007/BF00561656. Eur J Clin Pharmacol. 1976. PMID: 9301
• [Effect of chronic beta-adrenergic blockade on blood pressure and release of renin, aldosterone and cortisol in essential hypertension (author's transl)].

  Stumpe KO, Vetter H, Hessenbruch V, Düsing R, Kolloch R, Krück F. Stumpe KO, et al. Klin Wochenschr. 1975 Oct 1;53(19):907-11. doi: 10.1007/BF01468983. Klin Wochenschr. 1975. PMID: 241876 Clinical Trial. German.